Archive for category: Uncategorized

April 1, 2024 Letter of Intent to Apply for a Large Grant (Two-year grant of up to $172,500)
‍
May 1, 2024 Seed Grant (Great for pilot studies! One year grant for up to $46,000)

May 1, 2024 Dissertation Grants (Up to $5,000)

June 3, 2024 Special Initiative on the Language and Messaging of Prevention and Responsible Gambling Programs (Three-year grant up to $402,500)

June 10, 2024 Special Initiative on Sex, Gender and Gambling (Two-year grant of up to $172,500)

June 24, 2024 Special Initiative on Gambling industry Employees (Two-year grant of up to $172,500)

‍

Click here for announcements and application forms!

Questions? Contact Christine Reilly, Senior Research Director (creilly@icrg.org).

Thanks to the generosity of the San Manuel Band of Mission Indians, the ICRG has added a new position to its staff. The Director of Tribal Nations Relations and Communications will work to expand ICRG’s relations with Native American tribes involved in tribal gaming and develop a comprehensive marketing and communications strategy for ICRG.

RESPONSIBILITIES

●Serve as staff liaison to the ICRG board’s Tribal Gaming Initiatives Committee.

●Provide input in all ICRG’s tribal-related efforts.

●Coordinate the annual conference for treatment providers in cooperation with the Sandia Resort and Casino in New Mexico; specifically, research and invite speakers and prepare promotional materials for the event.

●Promote the adoption of the Sandia conference model in other jurisdictions and coordinate those programs.

●Help the President and Senior Fundraiser source funds from tribal gaming entities for support of research and education on gambling disorder and responsible gambling.

●Coordinate all communications and marketing for the ICRG including news releases, monitoring ICRG profile in the media, handling all media inquiries to ICRG, social media, website updates and promotion of ICRG educational programs.

●This position requires travel approximately 25% of the time

QUALIFICATIONS

●Minimum of B.A. degree

●Two years of nonprofit management/university experience

●Excellent writing skills and experience with communications and marketing

●Excellent interpersonal skills: the ability to interact with diverse internal and external constituents.

●Ability to manage multiple projects simultaneously, working both independently and as a team member.

●Familiarity with tribal gaming is required.

●Deep understanding of tribal life and customs required.

‍

Remote work is possible.

‍

Send cover letter and resume to Christine Reilly (creilly@icrg.org).

‍REQUEST FOR APPLICATIONS

RESEARCH ON PRE-COMMITMENT AS A PREVENTION MEASURE TO REDUCE GAMBLING-RELATED HARMS

Application Deadline: May 15, 2023

The International Center for Responsible Gaming (ICRG) invites investigators to apply for a two-year Large Grant to study the efficacy of “pre-commitment,” a prevention strategy that allows gamblers to set limits on money and time spent gambling. Applicants may request up to a total of $75,000 per year up to two years plus 15 percent in Facilities & Administration costs. Total amount that may be requested is $172,500.

The International Center for Responsible Gaming

The ICRG is a global leader in research and education on gambling disorder and responsible gambling. Since 1996, the ICRG (formerly the National Center for Responsible Gaming) has conducted rigorous competitions for research grant funds. The ICRG grants program is monitored by the Scientific Advisory Board, an independent panel of leading scientists with expertise in addiction and related topics. The Scientific Advisory Board plays a vital role by ensuring that the ICRG follows rigorous standards in awarding grants for only the highest quality research proposals. See page 11 for a list of current members. 

Funding

The funding for this initiative is from Global Payments (www.globalpayments.com). The ICRG will award one grant through this initiative. The ICRG maintains a firewall to protect the integrity of research supported with funds from the gambling sector. Visit www.icrg.org to see details about the firewall.

Eligible Applicants

Domestic or international, public or private, non-profit or for-profit organizations are eligible to apply for ICRG funding.  The Principal Investigator must have a PhD, MD, or other terminal degree. 

Research on Pre-Commitment

Most scientists working on prevention and responsible gambling agree that enabling players to make informed decisions about their gambling is a productive strategy for reducing gambling-related harms. Informed decision-making can be encouraged by educating players about the benefits of limiting their gambling expenditures to within an affordable amount of money as well as time spent gambling before play begins (i.e., pre-commitment). The supposition is that if a player pre-commits to a limit in a non- emotionally arousing state before gambling that player will: a) set a limit that is within his or her means; and b) adhere to his or her limit when notified that it has been reached. 

Unfortunately, this is an under-developed area of research, especially in North America. Investigations of the effectiveness and acceptability of mandatory and voluntary pre-commitment are lacking.  More investigations using real-life settings without relying on samples of convenience (e.g., college students) are needed. 

The ICRG seeks to fund research that assesses the effectiveness of voluntary and/or mandatory pre-commitment programs (through either online or land-based gambling venues) under real life conditions. The ICRG encourages applicants to design research programs that not only determine the effectiveness of such programs but also offer insights for improving existing pre-commitment strategies. 

Review Process and Criteria

 The ICRG seeks proposals of high scientific merit from investigators who show promise of disseminating their work at high-impact conferences and in prestigious, peer-reviewed scientific journals. 

An appropriate scientific review group convened in accordance with the standard ICRG peer review procedures, modeled on those of the National Institutes of Health (NIH), will evaluate applications for scientific and technical merit.

As part of the initial review, all applications:

• May undergo a selection process in which only those applications deemed to have the highest scientific merit, generally the top half of applications under review, will be discussed and assigned a priority score.
• Will receive a written critique in the Summary Statement.
• Will receive a second level of review by the Scientific Advisory Board, which makes the final funding decisions.

The peer review panel will evaluate proposals according to the following criteria, adapted from the NIH: 

1. Significance. Does the project address an important problem or a critical barrier to progress in the field? If the aims of the project are achieved, how will scientific knowledge, technical capability and/or clinical practice be improved? How will successful completion of the aims change the concepts, methods, technologies, treatments, services or preventative interventions that drive this field?
2. Investigator(s). Are the Principal Investigator (PI), collaborators and other researchers well suited to the project? If the project is collaborative, do the investigators have complementary and integrated expertise; are their leadership approach, governance and organizational structure appropriate for the project? 
3. Innovation. Does the application challenge and seek to shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation or interventions? Are the concepts, approaches or methodologies, instrumentation or interventions novel to one field of research or novel in a broad sense? Is a refinement, improvement or new application of theoretical concepts, approaches or methodologies instrumentation or interventions proposed? 
4. Approach. Are the overall strategy, methodology and analyses well-reasoned and appropriate to accomplish the specific aims of the project? Are potential problems, alternative strategies and benchmarks for success presented? If the project involves clinical research, are the plans for protection of human subjects from research risks justified in terms of the scientific goals and research strategy proposed? 
5. Environment. Will the scientific environment in which the work will be done contribute to the probability of success? Are the institutional support, equipment and other physical resources available to the investigators adequate for the project proposed? Will the project benefit from unique features of the scientific environment, subject populations or collaborative arrangements? 

Additional Review Criteria

In addition to the above criteria, the following items will be considered in the determination of scientific merit and the priority score:

• Protection of Human Subjects from Research Risk: The involvement of human subjects and protections from research risk relating to their participation in the proposed research will be assessed.
• Inclusion of Women, Minorities and Children in Research: The adequacy of plans to include subjects from both genders, all racial and ethnic groups (and subgroups), and children as appropriate for the scientific goals of the research will be assessed. Plans for the recruitment and retention of subjects will also be evaluated.
• Care and Use of Vertebrate Animals in Research: If vertebrate animals are to be used in the project, the five items described in PHS Form 398 research grant application instructions will be assessed.
• Biohazards: If materials or procedures are proposed that are potentially hazardous to research personnel and/or the environment, determine if the proposed protection is adequate.

Additional Review Considerations

• Budget: The reasonableness of the proposed budget and the requested period of support in relation to the proposed research plan.

Application Instructions

Please use the ICRG Large Grant application form available for download from the resource page. This application form provides the Face Page, Page 2 and the Budget pages. You may use the NIH Biosketch or download ICRG’s version from the “Apply for ICRG Funding” section of the website. The narrative section should be presented in your own document.

Application Outline

• Face Page (form provided)
• Page Two: Project Summary/Abstract, Senior/Key Personnel, Previous Support (form provided)
• Biographical sketches (form provided or use NIH form)
• Budget Summary and Justification for Year 1 (form provided)
• Budget Summary and Justification for Year 2 (form provided)
• Research Plan (your own document)
• Human Subjects/Vertebrate Animals (your own document)
• Appendix: letters of support, citations, other materials. If human subjects are involved in the research project, download the Targeted/Planned Enrollment Form from the ICRG website and include in the Appendix.

Face Page (1 page)

Insert text into the shaded areas on the Face Page form.

The Principal Investigator (PI) is the person responsible for the scientific and technical direction of the project and is the primary contact for the ICRG. Provide full name, degree(s), title, department, institution, mailing address, telephone number and email address. 

Date of Proposed Period of Support. Projects may begin on August 1, 2023 and conclude no later than July 31, 2025.

Funds Requested. Fill in the amounts requested for years 1 and 2. Total requests may not exceed $150,000 in direct costs. A Facilities & Administration rate higher than 15 percent of direct costs is not allowable.

Applicant Organization. The Applicant Organization is legally and financially responsible for the conduct of activities supported by the award. Provide the name and contact information of the Applicant Organization’s Administrative Contact. 

Regulatory Approvals. Please check the appropriate box to indicate the use of animals (IACUC) or human subjects (IRB) in the proposed project. Note that the Principal Investigator must provide a copy of the IACUC and/or IRB letter to the ICRG before award funds will be released. Pending approvals at the time of application submission are acceptable. 

Certifications. Provide the electronic signatures of the Principal Investigator and the Official Signing for the Organization by typing names in the shaded box and checking the box “Confirm Signature.” 

Page 2: Project Summary/Abstract; Senior/Key Personnel; Previous Support (1 page) 

Insert text in the shaded areas on the form provided. 

Project Summary/Abstract. Provide a succinct and accurate description of the proposed work suitable for dissemination to the public. State the application’s broad, long-term objectives and specific aims. Describe concisely the research design and methods for achieving the stated goals. 

Senior/Key Personnel. In addition to the Principal Investigator, Senior/Key Personnel are defined as individuals who contribute to the scientific development or execution of the project in a substantive, measurable way, whether or not salaries are requested. In addition, stakeholders should be included under Key Personnel. Stakeholders are defined as individuals affected by the proposed research project. For example, a stakeholder might be a treatment provider involved in a clinical trial. List the Principal Investigator, last name first. Then list all other Senior/Key Personnel in alphabetical order, last name first. For each individual, provide name, institutional affiliation and role on the project. 

Previous Support from the ICRG. Please list the title of any grant awards to the Principal Investigator from the International Center for Responsible Gaming, the National Center for Responsible Gaming, and the Institute for Research on Pathological Gambling and Related Disorders. Identify products resulting from the grant(s), such as publication in a peer- reviewed journal, a poster or presentation at a conference or subsequent support from NIH or another funding entity to continue the research project. 

Biographical Sketches 

Biographical Sketches of the Principal Investigator and Senior/Key personnel should be included (maximum of five pages each). Please use the NIH form or download the biosketch form.

Budget (2 pages) 

Present the proposed budget for years 1 and 2 on the forms provided. 

Allowable Cost Items

• Personnel. Allowable personnel expenses include salary and applicable fringe benefits for the Principal Investigator, post-docs and graduate students (if they receive a salary) and other professional and technical staff.
• Consultant Costs. Identify consultants by name and estimate the number of days of service and rate of compensation.
• Equipment. Only equipment essential to the conduct of this project is allowed. 
• Human subjects. Costs of recruitment (e.g., purchase of advertising), payments to subjects, patient care and other costs associated with the use of participants in the study. 
• Facilities & Administration costs. Up to 15 percent of the total direct costs.
• Travel. ICRG grantees are required to present a poster at the annual ICRG Conference on Gambling and Addiction. Budget for travel to the conference in Las Vegas, Nevada in the second year of the grant. 

Unallowable Cost Items 

Funding will not be provided for the following:

• Administrative personnel 
• Stipends
• Office equipment and furniture
• Tuition
• Dues and membership fees
• Maintenance/service contracts
• Construction, alteration, maintenance or rental of buildings or building space
• Recruiting/relocation expenses
• Entertainment/social expenses

Budget Justification 

In the space below the Budget Summary, explain and justify costs presented, providing calculations to demonstrate how amounts were determined. Enter text in the shaded area on the form provided. 

Research Plan (Maximum 15 pages) 

This section should be presented in your own document. Please observe the following formatting requirements: 

• Arial 11-point font
• A smaller type size may be used in figures, graphs, diagrams, charts, tables, figure legends and footnotes. However, applicants should use their judgment and avoid the use of excessively small type that would be difficult to read.
• Type density, including characters and spaces, must be no more than15 

characters per inch. Type may be no more than six lines per inch.

• Margins of at least one half inch on all sides on all pages.
• Single-column format for text
• Standard paper size (8.5” X 11”)
• Paginate all pages 

Use any word processing software to create the text. Then, convert to a PDF using a PDF creation software such as Adobe® Acrobat® Professional. Scanning hard copies to produce a PDF typically results in excessively large files that can be difficult to e- mail or open and, therefore, will not be accepted for review. 

Please follow the outline provided below. 

Specific Aims. State the goals of the proposed research and summarize the expected outcome(s), including the impact that the results of the proposed research will exert on the research field(s) involved. List the specific objectives of the research proposed (e.g., to test a stated hypothesis, create a novel design, solve a specific problem, challenge an existing paradigm or clinical practice, address a critical barrier to progress in the field or develop new technology). 

Research Strategy. Organize the Research Strategy section according to the following outline: 

(a) Significance

• Explain the importance of the problem or critical barrier to progress in the field that the proposed project addresses.

• Explain how the proposed project will improve scientific knowledge, technical capability and/or clinical practice in one or more broad fields.
• Describe how the concepts, methods, technologies, treatments, services or preventative interventions that drive this field will be changed if the proposed aims are achieved. 

(b) Innovation

• Explain how the application challenges and seeks to shift current research or clinical practice paradigms.
• Describe any novel theoretical concepts, approaches or methodologies, instrumentation or intervention(s) to be developed or used, and any advantage over existing methodologies, instrumentation or intervention(s). 
• Explain any refinements, improvements or new applications of theoretical concepts, approaches or methodologies, instrumentation or interventions. 

(c) Approach

• Describe the overall strategy, methodology and analyses to be used to accomplish the specific aims of the project. Include how the data will be collected, analyzed and interpreted as well as any resource sharing plans, as appropriate. A data sharing plan or an explanation of why data sharing is not feasible is expected to be included in all applications where the generation of data is anticipated. Reviewers will assess the reasonableness of the data sharing plan or the rationale for not sharing research data. 
• Discuss potential problems, alternative strategies and benchmarks for success anticipated to achieve the aims. 

(d) The Relevance and Societal Impact of the Proposed Research. 

Protection of Human Subjects/Vertebrate Animals (Maximum 2 Pages)
Protection of Human Subjects
If applicable, summarize your plan to protect human subjects according to the following outline: 

1) Risks to Human Subjects

a) Human Subjects’ Involvement and Characteristics 

• Describe the proposed involvement of human subjects in the work outlined in the Research Plan section. 
• Describe the characteristics of the subject population, including their anticipated number, age range and health status. 
• Identify the criteria for inclusion or exclusion of any subpopulation.
  Explain the rationale for the involvement of special classes of subjects, such as fetuses, neonates, pregnant women, children, prisoners, institutionalized individuals or others who may be considered vulnerable populations. Note that “prisoners” includes all subjects involuntarily incarcerated (for example, in detention centers) as well as subjects who become incarcerated after the study begins. 
• List any collaborating sites where human subjects research will be performed and describe the role of those sites and collaborating investigators in performing the proposed research. 

b) Sources of Materials 

• Describe the research material obtained from living individuals in the form of specimens, records or data. 
• Describe any data that will be collected from human subjects for the project described in the application. 
• Indicate who will have access to individually identifiable private information about human subjects. 
• Provide information about how the specimens, records or data are collected and whether material or data will be collected specifically for the proposed research project. 

c) Potential Risks 

• Describe the potential risks to subjects (physical, psychological, financial, legal or other), and assess their likelihood and seriousness to the subjects. 
• Where appropriate, describe alternative treatments and procedures, including the risks and potential benefits of the alternative treatments and procedures, to participants in the proposed research. 

2) Adequacy of Protection Against Risks 

a) Recruitment and Informed Consent 

• Describe plans for the recruitment of subjects (where appropriate) and the process for obtaining informed consent. If the proposed studies will include children, describe the process for meeting requirements for parental permission and child assent.
• Include a description of the circumstances under which consent will be sought and obtained, who will seek it, the nature of the information to be provided to prospective subjects and the method of documenting consent. If a waiver of some or all of the elements of informed consent will be sought, provide justification for the waiver. 

b) Protections Against Risk 

• Describe planned procedures for protecting against or minimizing potential risks, including risks to privacy of individuals or confidentiality of data, and assess their likely effectiveness. 
• Research involving vulnerable populations, as described in the DHHS regulations, Subparts B-D, must include additional protections. Refer to DHHS regulations, and OHRP guidance (www.hhs.gov/ohrp). 
• Where appropriate, discuss plans for ensuring necessary medical or professional intervention in the event of adverse effects to the subjects. Studies that involve clinical trials (biomedical and behavioral intervention studies) must include a general description of the plan for data and safety monitoring of the research and adverse event reporting to the IRB and others, as appropriate, to ensure the safety of participants. 

3.) Potential Benefits of the Proposed Research to Human Subjects and Others 

• Discuss the potential benefits of the research to human subjects and others.
• Discuss why the risks to subjects are reasonable in relation to the anticipated benefits to research participants and others. 

4)  Importance of the Knowledge to be Gained 

• Discuss the importance of the knowledge gained or to be gained as a result of the proposed research. 
• Discuss why the risks to subjects are reasonable in relation to the importance of the knowledge that reasonably may be expected to result. 

5)  Data and Safety Monitoring Plan 

If the research includes a clinical trial, create a heading entitled “Data and Safety Monitoring Plan.” 

• Provide a general description of a monitoring plan that you plan to establish as the overall framework for data and safety monitoring.
• Describe the entity that will be responsible for monitoring and the process by which Adverse Events will be reported. 

Vertebrate Animals 

If vertebrate animals are involved in the project, address each of the five points below. 

1)  Provide a detailed description of the proposed use of the animals for the work outlined in the Research Plan Narrative. Identify the species, strains, ages, sex and numbers of animals to be used in the proposed work. 

2)  Justify the use of animals, the choice of species and the numbers to be used. If animals are in short supply, costly, or to be used in large numbers, provide an additional rationale for their selection and numbers. 

3)  Provide information on the veterinary care of the animals involved. 

4)  Describe the procedures for ensuring that discomfort, distress, pain and injury will be limited to that which is unavoidable in the conduct of scientifically sound research. Describe the use of analgesic, anesthetic, and tranquilizing drugs, and/or comfortable restraining devices, where appropriate, to minimize discomfort, distress, pain and injury. 

5)  Describe any method of euthanasia to be used and the reason(s) for its selection. State whether this method is consistent with the recommendations of the American Veterinary Medical Association (AVMA) Guidelines on Euthanasia. If not, include a scientific justification for not following the recommendations. 

Appendix 

The Appendix may include items such as a list of references cited, letters of support (e.g., to demonstrate institutional or community support for the project), and other supporting materials. In addition, if the research plan involves human subjects, please include a targeted/planned enrollment form, available for download from the resource page at www.icrg.org.

Submission Process 

Create a single PDF document with the PI’s name as the title. Use a PDF creation software such as Adobe® Acrobat® Professional to create the PDF rather than scanning hard copies to produce a PDF. Such files can be difficult to email to open and, therefore, will not be accepted for review. 

Send proposal via email to Christine Reilly, Senior Research Director (creilly@icrg.org) by 5 p.m. (Eastern) ON MAY 15, 2023.

Questions? Contact Christine Reilly (creilly@icrg.org; 978-338-6610). 

ICRG Scientific Advisory Board 

Chair 

Linda B. Cottler, PhD, MPH 

Dean’s Professor, Department of Epidemiology

College of Medicine and College of Public Health and Health Professions

University of Florida 

Board Members 

Tammy Chung, PhD 

Director, Center for Population Behavioral Health, Professor of Psychiatry
Rutgers, The State University of New Jersey 

David C. Hodgins, PhD 

Professor of Psychology 

University of Calgary 

Miriam Jorgensen, PhD 

Research Director, Native Nations Institute
University of Arizona
Research Director
Harvard Project on American Indian Economic Development Harvard University 

Gloria Miele, PhD 

Program Director, Opioid and Stimulant Implementation Support UCLA Integrated Substance Abuse Programs
Chair, UCLA ISAP Continuing Medical Education Committee 

T. Celeste Napier, PhD 

Professor of Psychiatry
Director, Center for Compulsive Behavior and Addiction 

Rush University 

International Center for Responsible Gaming 

900 Cummings Center, Suite 219-U

 Beverly, MA 01915
Tel: 978-338-6610
Fax: 978-522-8452 www.icrg.org

‍